Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma.

McNeal JE, Yemoto CE.

Am J Surg Pathol. 1996 Nov;20(11):1351-60.

PMID:
8898839
2.

Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.

Ferrari MK, McNeal JE, Malhotra SM, Brooks JD.

Urology. 2004 Oct;64(4):749-53.

PMID:
15491714
3.

Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.

Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.

J Urol. 2005 Dec;174(6):2181-5.

PMID:
16280760
4.

Microvascular invasion in prostate cancer: prognostic significance in patients treated by radical prostatectomy for clinically localized carcinoma.

van den Ouden D, Kranse R, Hop WC, van der Kwast TH, Schröder FH.

Urol Int. 1998;60(1):17-24.

PMID:
9519416
5.

Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.

Wheeler TM, Dillioglugil O, Kattan MW, Arakawa A, Soh S, Suyama K, Ohori M, Scardino PT.

Hum Pathol. 1998 Aug;29(8):856-62.

PMID:
9712429
6.

Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations.

McNeal JE, Yemoto CE.

Am J Surg Pathol. 1996 Jul;20(7):802-14.

PMID:
8669528
7.

Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.

Maru N, Ohori M, Kattan MW, Scardino PT, Wheeler TM.

Hum Pathol. 2001 Aug;32(8):828-33.

PMID:
11521227
8.

An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.

Noguchi M, Stamey TA, Neal JE, Yemoto CE.

J Urol. 2000 Jun;163(6):1751-5.

PMID:
10799175
9.

Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.

Epstein JI, Partin AW, Potter SR, Walsh PC.

Urology. 2000 Aug 1;56(2):283-8.

PMID:
10925095
10.
11.

Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy.

Freedland SJ, Aronson WJ, Presti JC Jr, Amling CL, Terris MK, Trock B, Kane CJ.

Cancer. 2004 Apr 15;100(8):1633-8.

12.
13.

The independent impact of extended pattern biopsy on prostate cancer stage migration.

Master VA, Chi T, Simko JP, Weinberg V, Carroll PR.

J Urol. 2005 Nov;174(5):1789-93; discussion 1793.

PMID:
16217288
14.

Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.

Salomon L, Anastasiadis AG, Johnson CW, McKiernan JM, Goluboff ET, Abbou CC, Olsson CA, Benson MC.

Urology. 2003 Aug;62(2):304-9.

PMID:
12893340
15.
16.

Development of prostatic carcinoma. Morphometric and pathologic features of early stages.

Villers AA, McNeal JE, Freiha FS, Stamey TA.

Acta Oncol. 1991;30(2):145-51.

PMID:
1851426
17.

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy.

Chan TY, Partin AW, Walsh PC, Epstein JI.

Urology. 2000 Nov 1;56(5):823-7.

PMID:
11068310
18.

Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors.

Brooks JP, Albert PS, Wilder RB, Gant DA, McLeod DG, Poggi MM.

J Urol. 2005 Dec;174(6):2204-8, discussion 2208.

PMID:
16280764
19.

Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.

Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK.

Urology. 2004 Jul;64(1):84-9.

PMID:
15245941
20.

Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications.

Rubin MA, de La Taille A, Bagiella E, Olsson CA, O'Toole KM.

Am J Surg Pathol. 1998 Jul;22(7):840-8.

PMID:
9669346

Supplemental Content

Support Center